Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.
In a study published in Science Immunology, researchers have shown that natural killer cells (NK cells), which are a fundamental part of the body’s immune system, can recognise many different viruses including global pathogens such as Zika, dengue and Hepatitis C viruses, through a single receptor called KIR2DS2.
Lead researcher Salim Khakoo, Professor of Hepatology, said the findings are very exciting and could change the way viruses are targeted by vaccines but warned that the research is still at an early stage, and animal studies/clinical trials will be needed to test the findings.
Vaccines work by stimulating the immune response to the coat of proteins on the virus enabling the body to fight off the virus and recognise it in the future. However, the viruses are able to change their coat proteins, helping the virus to evade the antibodies, meaning some viruses can be very hard to vaccinate against.
The Southampton team have shown that this NK cell receptor is able to target a non-variable part of the virus called the NS3 helicase protein, which is essential in making the virus work properly. Unlike other proteins, the NS3 helicase protein does not change, which allows the immune system to grab hold of it and let the NK cells deal with the threat.
Professor Khakoo said: “The NS3 helicase protein could be the key in unlocking the defence of lethal viruses that affect so many people around the world. It is very exciting to discover that other viruses similar to Hepatitis C, such as Zika virus, dengue virus, yellow fever virus, Japanese encephalitis virus and in fact all flaviviruses, contain a region within their NS3 helicase proteins that is recognised by exactly the same KIR2DS2 receptor. We believe that by targeting this NS3 helicase region, we could make a new type of vaccine based upon natural killer cells, which can be used to help protect people from these infections.”
The study, which was funded by the Wellcome Trust and the Medical Research Council, analysed DNA from more than 300 patients exposed to the Hepatitis C virus, which showed that the KIR2DS2 receptor was associated with successfully clearing the virus. The team then identified that the immune system targeted the NS3 helicase protein of this using the receptor and found that it prevented the virus multiplying.
They went on to demonstrate that this same mechanism icould be important for many different viruses for example the Zika and dengue viruses, which also contain a region within their NS3 helicase protein that is recognised by the KIR2DS2 receptor.
The researchers now need to determine whether these KIR2DS2+ NK cells are protective during acute flaviviral infections, and are hoping to develop a vaccine that targets natural killer cells. They believe that a similar process could be used to target cancer.
Professor Khakoo added: “Cancer treatments that use the body’s own immune system are becoming more common. Our findings present a completely new strategy for virus therapeutics which could be easily translated into the field of cancer. The next few years are going to be very exciting in this field.”
The Latest on: Vaccine for viruses
- Despite weakening vaccine interest, Iowa confirms 9 COVID-19 deaths over weekendon May 2, 2021 at 4:42 pm
Iowa counties that declined all or some of this week’s doses of the COVID-19 vaccine because of waning interest confirmed five of the nine virus-related deaths reported this weekend in the state, ...
- Many police officers spurn coronavirus vaccines as departments avoid mandateson May 2, 2021 at 4:07 pm
Police officers were among the first front-line workers to gain priority access to coronavirus vaccines. But their vaccination rates are lower than or about the same as those of the general public, ...
- So coronavirus vaccines aren’t perfect. They’re still very, very effectiveon May 2, 2021 at 4:07 pm
It was already clear from the clinical trials that the current vaccines weren’t perfect. No vaccine is. But the rate of infection among the immunized has been extremely low, with COVID-19 ...
- U.S. Seeks Expanded Access in Global Vaccine Talks: Virus Updateon May 2, 2021 at 3:56 pm
Talks starting this week between the U.S. and World Trade Organization over expanding access to vaccines will focus on how to get them “widely distributed, more widely licensed, more widely shared,” ...
- Massachusetts coronavirus vaccine rollout: 2.6 million people fully vaccinated, lowest single-day case count since Novemberon May 2, 2021 at 2:42 pm
More than 37,000 coronavirus vaccine doses were administered in Massachusetts during the most recent day of vaccination data, as more than 2.6 million people in the state are now fully vaccinated.
- These vaccine ‘fairies’ have booked hundreds of shots for Latino essential workerson May 2, 2021 at 12:00 pm
A small group of volunteers works late at night to book appointments for Latino residents who have had difficulty navigating the system.
- Covid-19 Live News: In India’s Crisis, the Virus Rages Amid Vaccine Shortageson May 2, 2021 at 3:20 am
One of the worst U.S. outbreaks is in Fairbanks, Alaska. In Oregon, 15 counties are now under the state’s severest restrictions.
- Will Covid-19 vaccines reduce virus transmission?on May 2, 2021 at 12:37 am
There are two ways that getting vaccinated can slow the spread of the virus. First, it can help prevent you getting infected. Second, even if you are unlucky and catch the virus, it may reduce the ...
- Vaccine campaign begins amid virus surge in rebel-held Syriaon May 1, 2021 at 9:51 pm
A COVID-19 vaccine campaign kicked off in Syria’s last rebel-held enclave on Saturday, with a 45-year-old front-line nurse becoming the first to receive a U.N.-secured jab. Nizar Fattouh, a nurse in ...
- Trisha Yearwood Is 'Grateful' to Receive the First Dose of COVID Vaccine After Contracting Viruson May 1, 2021 at 8:30 am
Trisha Yearwood/Instagram . Trisha Yearwood is expressing her gratitude for receiving her first dose of the COVID-19 vaccine. The country star, 56, posted a photo of her vaccine a ...
via Google News and Bing News